Mammalian mitogen-activated protein (MAP) 1 kinases are serine/threonine kinases that mediate intracellular signal transduction pathways (1, 2) . Members of the MAP kinase family share sequence similarity and conserved structural domains and include the extracellular signal-regulated kinases (ERKs), Jun N-terminal kinases (JNKs), and p38 kinase. ERK is activated by mitogen and growth factors via a Ras-dependent pathway (3) . In contrast, JNK and p38 kinases are activated in response to the pro-inflammatory cytokines tumor necrosis factor-␣ (TNF␣) and interleukin-1 (IL-1), ultraviolet irradiation, and cellular stress, including heat shock and inhibitors of protein synthesis (4 -6) .
MAP kinases must be phosphorylated to achieve maximum enzymatic activity (7) . MAP kinases are activated by phosphorylation on Thr and Tyr within a Thr-X-Tyr motif by specific upstream MAP kinase kinases, where X is Pro, Glu, and Gly for ERK, JNK, and p38, respectively (1, 2) . Because the Thr-X-Tyr motif is located in a surface loop near the active site, the loop is often referred to as the "phosphorylation lip" or "activation lip." Two MAP kinase kinases, MKK3 and MKK6, have been identified as p38-specific kinases that do not phosphorylate JNK (8 -10) , suggesting that activation of p38 kinase is mediated by a distinct but parallel signaling pathway to that of JNK.
p38 kinase phosphorylates and activates transcription factors ATF-2 and CHOP-1 (10, 11) , indicating a role of p38 kinase in transcriptional regulation. Recently, p38 was identified as the target for a group of pyridinyl imidazole compounds that block the production of IL-1 and TNF␣ from monocytes stimulated by endotoxin (12) . p38 kinase has also been implicated in activation of MAPK-activated protein kinase-2 (13), activation of platelets (14, 15) , production of IL-6 and IL-8 (16) , and apoptosis of neuronal cells (17) . Modulation of p38 kinase activity could therefore provide therapeutic intervention for disorders ranging from inflammatory diseases to Alzheimer's disease. To understand the regulation of p38 MAP kinase, and to facilitate the design of specific p38 inhibitors, we have determined the high resolution crystal structure of apo, unphosphorylated human p38 kinase.
MATERIALS AND METHODS

Generation of Baculovirus Transfer Vectors and Recombinant
Virus-Two splice variants of human p38 kinase, CSBP1 and CSBP2, have been identified (12) . Specific oligonucleotide primers were used to amplify the coding region of CSBP2 cDNA using a HeLa cell library (Stratagene) as template. The polymerase chain reaction product was cloned into the pET-15b vector (Novagen). The baculovirus transfer vector, pVL-(His) 6 -p38 was constructed by subcloning a XbaI-BamHI fragment of pET15b-(His) 6 -p38 into the complementary sites in plasmid pVL1392 (Pharmingen). The plasmid pVL-(His) 6 -p38 directs the synthesis of a recombinant protein consisting of a 23-residue peptide (MGSSHHHHHHSSGLVPRGSHMLE, where LVPRGS represents a thrombin cleavage site) fused in frame to the N terminus of p38, as confirmed by DNA sequencing and by N-terminal sequencing of the expressed protein. Monolayer culture of Spodoptera frugiperda (Sf9) insect cells (ATCC) was maintained in TNM-FH medium (Life Technologies, Inc.) supplemented with 10% fetal bovine serum in a T-flask at 27°C. Sf9 cells in log phase were co-transfected with linear viral DNA of Autographa califonica nuclear polyhedrosis virus (Pharmingen) and transfer vector pVL-(His) 6 -p38 using Lipofectin (Invitrogen). The individual recombinant baculovirus clones were purified by plaque assay using 1% low melting agarose.
Expression of p38 from Insect Cells-The Trichoplusia ni (Tn-368) High-Five™ cells (Invitrogen) were grown in suspension in Excel-405 protein-free medium (JRH Bioscience) in a shaker flask at 27°C. Cells at a density of 1.5 ϫ 10 6 cells/ml were infected with recombinant baculovirus at a multiplicity of infection of 5. The expression level of recombinant p38 was monitored with immunoblotting using a rabbit anti-p38 antibody (Santa Cruz Biotechnology). The cell mass was harvested 72 h after infection when the expression level of p38 reached its maximum.
Purification of p38 Kinase-Typically, 20 -30 g of the frozen cells were thawed and resuspended in 5 volumes of Buffer A (50 mM NaH 2 PO 4, pH 8.0, 200 mM NaCl, 2 mM ␤-mercaptoethanol, 10% glycerol, and 0.2 mM PMSF). After mechanical disruption of the cells in a microfluidizer (Microfluidics Corp., Newton, MA), the lysate was centrifuged at 30,000 ϫ g for 30 min. The supernatant was incubated for 3-5 h at 4°C with Talon™ (Clontech) metal affinity resin at a ratio of 1 ml of resin/5 ml of supernatant. The resin was settled and washed with 10 volumes of Buffer A. The washed resin was slurried and poured * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1WFC) have been deposited in the Protein Data Bank, Brookhaven National Laboratory, Upton, NY.
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into a column (approximately 2.6 ϫ 5.0 cm) and washed with 2 column volumes of Buffer A containing 5 mM imidizole. The bound histidinetagged p38 protein was eluted by increasing the imidazole concentration of the buffer A to 100 mM. The pooled fraction (200 mg of protein in 50 ml) was dialyzed overnight at 4°C against 2 liters of Buffer B (25 mM HEPES, pH 7.5, 25 mM ␤-glycerophosphate, 5% glycerol, 2 mM DTT). The histidine tag was removed by adding 1.0 unit of thrombin (Calbiochem)/mg of p38 for 2-3 h at 20°C. After thrombin cleavage, 6 amino acid residues (GSHMLE) from the tag remain on the N terminus of the recombinant p38 protein, as confirmed by protein sequencing. When proteolysis appeared complete, as judged by SDS-PAGE analysis, the thrombin activity was quenched by addition of 0.2 mM of PMSF. The sample was passed through a 2-ml column of benzamidine-agarose (American International Chemical). The flow-through fraction was loaded onto a 2.6 ϫ 5.0 cm Q-Sepharose (Pharmacia Biotech Inc.) column equilibrated in Buffer B containing 0.2 mM PMSF. Protein was eluted by a linear salt gradient of 0 -0.6 M NaCl in 20 column volumes of Buffer B. The p38 eluted as a single peak at about 0.35 M NaCl. The pooled p38 was dialyzed against Buffer C (50 mM HEPES, pH 7.5, 5% glycerol, 50 mM NaCl, 2 mM DTT, 0.2 mM PMSF) at 4°C. The dialyzed protein was incubated with 2 ml of anti-phosphotyrosine-agarose (Sigma) for 2 h and then was loaded into a small column. The flow-through fraction was concentrated in a Centriprep-10 (Amicon) to 3-4 ml and then subjected to size-exclusion chromatography on a column (2.6 ϫ 100 cm) of Sephacryl S-100HR (Pharmacia) at a flow rate of 0.5 ml/min of Buffer C. The main peak was pooled and appeared to be Ͼ99% pure by SDS-PAGE analysis. The protein solution was adjusted to 20 mM DTT, concentrated, and then used for crystallization experiments or frozen at Ϫ70°C.
Crystallization of p38 Kinase and Structure Determination-Crystals of unphosphorylated, apo-p38 were grown by vapor diffusion when protein (40 mg/ml in 50 mM HEPES, pH 7.5, 10 mM DTT, 0.1 M NaCl, 5% glycerol) was mixed with reservoir (40 mM NaHEPES, pH 7.5, 0.56 M sodium citrate, 130 mM (NH 4 ) 2 SO 4 ) at a 3 l:2 l protein solution to reservoir ratio and allowed to stand at room temperature. Crystals grew over 72 h to 0.35 ϫ 0.25 ϫ 0.03 mm in size and were then equilibrated slowly to a buffer of 0.5 M NaHEPES, pH 7.5, 0.7 M sodium citrate, 144 mM (NH 4 ) 2 SO 4 , and 15% glycerol in preparation for x-ray data collection at Ϫ169°C.
X-ray data were collected on an Raxis IIC image plate and processed using software provided by the manufacturer (Molecular Structures Corp. Woodlands, TX). The crystals had space group symmetry P2 1 2 1 2 1 , with unit cell dimensions a ϭ 45.2 Å, b ϭ 86.21 Å, and c ϭ 123.9 Å. R-merge for the data was 5.6%, with I/sig(I) ϭ 5.2 at 2.3 Å resolution. The x-ray data comprised 19,927 unique reflections with ͉F͉ Ͼ (F) derived from 43,442 intensity measurements. The data were 90% complete overall and 85% complete in the 2.4 -2.3 Å resolution shell. Analysis of the unit cell dimensions indicated that the asymmetric unit contained a single p38 protomer.
X-ray coordinates of ERK2 (18) were used to construct a model for p38. The side chain positions of conserved amino acids were included in the model, but residues that were different between p38 and ERK2 were truncated to alanine or glycine. Residues present in ERK2, but not in p38, were deleted, and all thermal factors were set to 10.0 Å 2 . This hybrid model produced a successful rotation and translation function solution for p38 using the program XPLOR (19) . Patterson correlation (PC) refinement of the top 25 rotation function solutions for the hybrid model indicated that the third highest rotation function peak (15.1) was correct. Additional PC refinement with the model divided into N-terminal (residues 16 -109 and 322-354) and C-terminal (residues 110 -321) domains increased the peak height to 17.7, suggesting that p38 was different than ERK2 in the relative orientation of the two halves of the enzyme. A translation search carried out using the structure corresponding to the highest peak after PC refinement produced a 28 peak, with the next peak at 20. This solution provided a starting model for p38 with an R-factor ϭ 45.2% for reflections between 10 and 3.5 Å resolution, and R-free ϭ 49.4% for 10% of the x-ray data set aside at the start of the refinement. The resolution of the maps and model was gradually increased to 2.3 Å resolution by cycles of model building, positional refinement, and thermal factor refinement, interspersed with torsional dynamics runs. All stages of model refinement were carried out using the XPLOR suite of programs. Our current p38 model contains 341 protein residues and 186 water molecules and has an R-factor of 21.3% (R-free ϭ 29.7%) versus all data with ͉F͉ Ͼ (F) between 6 and 2.3 Å resolution (18,762 reflections). PROCHECK and XPLOR were used to analyze the model stereochemistry. Ninety percent of the p38 residues were located in the most favored region of the -plot and 9% in the additional allowed regions. The model had deviations from ideal bond lengths and angles of 0.010 Å and 2.6°, respectively, and all other indications of stereochemistry were average or better then average for a structure determined at 2.3-Å resolution. No electron density was observed for p38 amino acids 1-4, 14 -15, 170 -174, and 353-360; therefore, these residues were not included in the model.
RESULTS AND DISCUSSION
Global Structure of p38 Kinase-p38 is a member of the MAP kinase family of protein kinases. p38 is 48% identical in amino acid sequence to ERK2, whose structure has been reported (18) , and 20 -25% identical to a number of other protein kinases whose structures have also been solved (see Refs. 7, 20, and 21 for reviews). Enzymes in this family are characterized by two domains separated by a deep channel where potential substrates might bind. The N-terminal domain creates a binding pocket for the adenine ring of ATP, and the C-terminal domain contains the presumed catalytic base, magnesium binding sites, and phosphorylation lip. Here we report the crystal structure of the apo, unphosphorylated, low activity form of p38 at 2.3 Å resolution.
Electron density for the main chain atoms of p38 is visible from residues 5-352, with breaks at residues 14 -15 and 170 -FIG. 1. Structure-based sequence alignment. Alignment of the human p38 (CSBP2) and rat ERK2 sequences based on structural similarity. Residues which have a C-␣ root mean square deviation of less than 2 Å when the N-and C-terminal domains are independently superposed are marked with an asterisk. The two structures deviate most at the protein termini, the interdomain hinge regions (around residues 110 and 320), and in a segment from amino acids 194 -201. Residues in lowercase have been modeled as alanine; residues in italics are not included in the model. Structural motifs are marked above the sequence and in boldface for segments in the C-terminal domain (18) . Roman numerals indicate conserved sequence motifs as described (22) . 174 . Four residues at the N terminus of p38, along with 6 amino acids remaining from the thrombin cleavage site, are not visible in the electron density map. Eight residues at the C terminus are also disordered. The presence of these amino acids in the crystal has been confirmed by sequence analysis. The phosphate anchor, which contains the consensus Gly-XGly-X-X-Gly sequence (residues 31-36 in p38) is mobile, with average B-values equal to 61 Å 2 . The sequence, fold, and topology of p38 are similar to ERK2 (Figs. 1 and 2) (18) . Independent superpositions of the upper and lower domains of ERK2 onto the p38 structure, ignoring the lip region and the protein termini, yield protein backbone root mean square deviations of 1.73 Å for the N-terminal domain (p38 residues 16 -109, 320 -346) and 1.75 Å for the Cterminal domain (p38 residues 110 -169, 185-318). Greater differences between ERK2 and p38 are observed when the whole proteins are compared. Superposition of the C-terminal domain of p38 onto the corresponding lobe of ERK2 revealed a rotation of the p38 domains by 12.2°relative to the orientation seen in ERK2 (Fig. 2) . Comparisons with other solved kinase structures indicates that the relative positions of the two domains in p38 is most similar to calmodulin-dependent protein kinase (23) .
Phosphorylation Lip-A large difference between ERK2 and p38 is observed in the positioning of the phosphorylation lip (Fig. 2) . The p38 activation lip corresponds to residues Gly 170 -Thr 185 , whereas the phosphorylation lip of ERK2 is 6 residues longer in sequence and spans amino acids Gly 167 -Thr 188 . The structure shows that Thr 180 and Tyr
182
, the p38 residues that are phosphorylated upon activation (24) , are located about 15 Å away from the locations of the corresponding residues in ERK2 (Thr 183 and Tyr 185 ). The shift changes the local environments of the 2 tyrosine residues. In the p38 structure, the Tyr 182 side chain is exposed to solvent and does not hydrogen-bond directly with any other residue. Instead, Tyr 182 interacts through a water molecule with the side chain hydroxyl group of Thr 221 . This water molecule has one of the lowest thermal factors (9.8 Å 2 ) for any solvent atom in the structure. In comparison, the Tyr 185 side chain in ERK2 is buried, forms a hydrogen bond with the side chain of Arg 146 , and makes van der Waals contacts with nearby hydrophobic amino acid side chains (18) . The environments and interactions of the 2 threonine residues are more similar. In p38, the Residues of the Unphosphorylated Lip Occupy the Peptide Binding Channel-Electron density for most of the p38 residues in the phosphorylation lip is strong, but no electron density is visible for residues 170 -174. Phe 169 , however, is well ordered. The next residue that can be seen in the electron density map is Thr 175 , which is 15 Å away. The 5 residues that connect these ends would need to adopt an extended conformation to span this distance. Taken together, the position of Phe 169 and Thr 175 , and the separation between these residues, indicates that p38 amino acids 170 -174, as well as residues 175-178 that are observed in the electron density map, occupy the peptide binding channel (Fig. 2) . This observation may explain in part the low activity observed with this form of p38, since these residues could interfere with substrate binding.
The p38 structure suggests how phosphorylation at Thr 180 and Tyr 182 might play a role in activating p38. A sulfate ion found in the ERK2 structure is hypothesized to be a marker for the binding site of the tyrosine phosphate (25) . In p38, this site is occupied by the backbone carbonyl of Met 179 . Arg 186 and Arg 189 are located nearby and are conserved among the MAP kinases. If the bound sulfate ion mimics the location of the phosphate, then Tyr 182 would move by approximately 15 Å upon phosphorylation to occupy this site, and refolding of the activation lip would be required. This movement might influence the location of other residues in the activation loop, including amino acids 170 -178, and could help to unblock the active site.
Active Site of p38 Kinase-The relative orientation of the two domains of p38 is different from that observed in ERK2 and other kinases. The twist results in misalignment of the two halves of the catalytic site of p38 by 2-2.5 Å when compared with the structure of the low activity form of ERK2 (18) and 3-5 Å when compared with the structure of cAMP-dependent protein kinase (Fig. 3) (26) . The cAPK structure contains ATP and a bound peptide inhibitor and is believed to represent the (12), has been isolated and differs by 14 residues between residues 230 and 254. These residues are marked by asterisks and are distant from the substrate binding site.
bioactive conformation (26) . The difference in domain orientation between p38 and cAPK is 25.7°and is significant because the rotation separates catalytic residues in the N-terminal domain of p38, such as residue Lys
53
, from those in the Cterminal domain, such as Asp 168 . Lys 53 and Asp 168 are essential for kinase activity of p38 (27) , and in the cAPK structure, the equivalent residues interact with the ATP ␤-phosphate and Mg 2ϩ ions. The structure suggests that the two domains of p38 would have to change their relative orientation to resemble more closely the conformation seen in the cAPK structure in order for catalysis to proceed.
Recognition of ERK2 and p38 by Upstream Activating Kinases-The number of residues in the activation lip among protein kinase family members is variable and ranges from 8 amino acids in calmodulin-dependent death-associated protein kinase (28) to 37 residues in LIMK2 (29) . Sequence homology through this region is low, and the structures of several protein kinases indicate that the conformation of the activation lip is not conserved (7, 20) . The sequence and structural variation of the lip among protein kinases could provide a recognition element for the upstream activating kinases in the cellular activation cascade. However, p38/ERK2 chimera proteins with the C-terminal region, including the lip, of p38 replaced by that of ERK2 still responded to cellular stimuli consistent with activation of the p38 pathway (30) . Additional experiments identified residues between sequence motifs III through VII as essential for recognition by the upstream activating kinase. The structures of p38 and ERK2 can be used to map the location of these residues. The results (Fig. 4) suggest that recognition of p38 and ERK2 by their upstream activating kinases takes place in regions remote from the activation lip. Furthermore, sequence comparisons with JNK2 indicate higher conservation with p38 than ERK2 in domains III through IV, an observation consistent with the overlap in activation of both p38 and JNK2 by MKK4 (8) .
The structure of the apo, unphosphorylated form of p38 reveals features that may be used in the regulation of an important cellular cascade. The domains of p38 are oriented so that the side chains of some key catalytic residues are misaligned by 3-5 Å. In addition, a portion of the p38 activation lip blocks the peptide substrate binding channel. The combination of these regulatory mechanisms helps to ensure that the p38 kinase activity is minimal before activation. Furthermore, rec- (30) , suggesting that surface residues corresponding to these motifs might interact with respective upstream kinases. A figure of solvent accessible surface of p38 was generated by the GRASP program (31) . Side chains of surface residues of p38 in motifs III through V, and motifs V through VII, that are different between p38 and ERK are colored red and blue, respectively (see Fig. 1 for reference) . The activation lip tyrosine and threonine residues are colored green with the location of the phosphate-accepting oxygen atoms marked by yellow. The results suggest that recognition of p38 and ERK2 by their upstream activating kinases takes place in regions remote from the activation lip. The combination of the data from these chimeras and mapping of the CSBP1 sequence onto the CSBP2 (Fig. 2) structure suggest that there would be little difference in the specificity for the upstream activating kinase for these two splice variants of p38.
FIG. 3.
Detailed comparison of active site. Ribbon diagrams of the ATP binding sites of p38 (yellow) and cAPK (red) are shown with the side chains of residues corresponding to p38 Glu 71 , Lys 53 , and Asp 168 . The p38 and cAPK structures were superposed using residues 126 -168 of p38 and 142-184 of cAPK on their C-terminal domains to illustrate the geometry of residues surrounding the active site. The backbone root mean square deviation of this region is 1.2 Å. ATP and two Mg 2ϩ ions from the cAPK structure are shown in magenta. Two hydrogen bonds from the adenine ring to the protein backbone in cAPK are shown by lines along with the corresponding backbone atoms in p38. The domain rotation of 25.7°b etween p38 and cAPK results in the misalignment of catalytic residues in the N-terminal domain, such as residue Lys 53 , with those in the C-terminal domain, such as residue Asp 168 . A conformational change in the glycine-rich phosphate anchor loop is apparent between the two structures. In cAPK this loop folds down onto the ATP molecule, while in the apo-p38 structure it is further removed by about 2 Å. ognition of p38 by upstream kinases likely involves residues that are distant to the activation lip. Structural and sequence similarities to p38 suggest that comparable regulatory mechanisms would apply to ERK2 and other MAP kinases.
